1. Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic. (March 2016) Authors: Au, Kin Man; Satterlee, Andrew; Min, Yuanzeng; Tian, Xi; Kim, Young Seok; Caster, Joseph M.; Zhang, Longzhen; Zhang, Tian; Huang, Leaf; Wang, Andrew Z. Journal: Biomaterials Issue: Volume 82(2016) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MODL-14. MODELING THE INTRATUMORAL HETEROGENEITY OF AGGRESSIVE GLIOBLASTOMA ON ORGANOTYPIC BRAIN SLICES TO OPTIMIZE TUMOR-HOMING TUMORICIDAL INSC TREATMENT. (14th November 2022) Authors: Zhang, Xiaopei; Dunn, Denise; Valdivia, Alain; Buckley, Andrew; Floyd, Scott; Hingtgen, Shawn; Satterlee, Andrew Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MODL-27. An organotypic brain slice culture platform as a novel pre-clinical model for diffuse intrinsic pontine glioma and diffuse midline glioma. (3rd June 2022) Authors: Mann, Breanna; Zhang, Xiaopei; Bell, Noah; Adefolaju, Adebimpe; Dasari, Rajaneekar; Valdivia, Alain; Buckley, Andrew; Quinsey, Carolyn; Hingtgen, Shawn; Satterlee, Andrew Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MODL-41. ORGANOTYPIC BRAIN SLICE CULTURE PLATFORM AS A NOVEL PRE-CLINICAL MODEL FOR PATIENT DERIVED CELL LINES. (14th November 2022) Authors: Mann, Breanna; Zhang, Xiaopei; Bell, Noah; Adefolaju, Adebimpe; Dasari, Rajaneekar; Hingtgen, Shawn; Satterlee, Andrew Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Novel murine tumour models depend on strain and route of inoculation1. Issue 4 (28th July 2016) Authors: Fu, Qiang; Satterlee, Andrew; Wang, Yongjun; Wang, Yuhua; Wang, Dun; Tang, Jingling; He, Zhonggui; Liu, Feng Journal: International journal of experimental pathology Issue: Volume 97:Issue 4(2016:Aug.) Page Start: 351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Quantitative Evaluation of the Mechanism Underlying the Biotransportation of the Active Ingredients in Puerariae lobatae Radix and Chuanxiong rhizoma. (15th June 2015) Authors: Liang, Xin‐Li; Zhang, Jing; Liao, Zheng‐Gen; Zhao, Guo‐Wei; Luo, Yun; Li, Zhe; Satterlee, Andrew Journal: Phytotherapy research Issue: Volume 29:Number 9(2015:Sep.) Page Start: 1396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SCIDOT-20. ADAPTING ENGINEERED CELL THERAPIES TO UNDERSTAND AND OVERCOME GLIOBLASTOMA RESISTANCE USING INTEGRATED IN VIVO AND EX VIVO MODELS. (11th November 2019) Authors: Satterlee, Andrew; Dunn, Denise; Floyd, Scott; Hingtgen, Shawn Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Theranostic etoposide phosphate/indium nanoparticles for cancer therapy and imaging. Issue 44 (22nd October 2015) Authors: Srinivas, Ramishetti; Satterlee, Andrew; Wang, Yuhua; Zhang, Yuan; Wang, Yongjun; Huang, Leaf Journal: Nanoscale Issue: Volume 7:Issue 44(2015) Page Start: 18542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. TMOD-31. ADAPTING ENGINEERED CELL THERAPIES TO UNDERSTAND AND OVERCOME GLIOBLASTOMA RESISTANCE USING INTEGRATED IN VIVO AND EX VIVO MODELS. (11th November 2019) Authors: Satterlee, Andrew; Dunn, Denise; Floyd, Scott; Hingtgen, Shawn Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. TMOD-31. AN ORGANOTYPIC TISSUE PLATFORM TO BRIDGE IN VITRO AND IN VIVO ASSAYS FOR BRAIN CANCER TREATMENT. (12th November 2021) Authors: Mann, Breanna; Bell, Noah; Dunn, Denise; Floyd, Scott; Hingtgen, Shawn; Satterlee, Andrew Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗